Related Experiment Video
Updated: Jan 21, 2026

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Fixed-dose combination of extended-release niacin plus simvastatin for lipid disorders
1Atherosclerosis Research Center, Department of Veteran Affairs Healthcare System, 5901 E. Seventh Street, Long Beach, CA 90822, USA. anthony.vo@med.va.gov
Insights
Combination therapy with niacin and statin effectively manages dyslipidemia, significantly improving lipid profiles and potentially reducing cardiovascular events in high-risk patients.
Area of Science:
- Cardiology
- Pharmacology
- Metabolic Disorders
Background:
- Coronary heart disease (CHD) remains a leading cause of global morbidity and mortality.
- Elevated LDL-cholesterol and low HDL-cholesterol are established CHD risk factors.
- Intensive LDL-lowering therapy alone has proven insufficient in preventing a majority of cardiovascular events.
Purpose of the Study:
- To evaluate the efficacy and safety of combination therapy for dyslipidemia.
- To assess the impact of niacin plus statin on various lipid parameters.
- To explore potential additive benefits in reducing CHD risk.
Main Methods:
- Utilized a fixed-dose combination of extended-release niacin and simvastatin.
- Compared the effects of combination therapy against statin monotherapy.
- Monitored changes in non-HDL-cholesterol, LDL-cholesterol, HDL-cholesterol, and triglycerides.
Main Results:
- Combination therapy significantly reduced non-HDL-cholesterol, LDL-cholesterol, and triglycerides by approximately 50%.
- HDL-cholesterol levels increased by approximately 25% with combination therapy.
- The safety profile of the combination was consistent with individual components and well-tolerated.
Conclusions:
- Niacin-statin combination therapy offers a broad beneficial effect on lipid profiles.
- This combination represents a promising approach for managing dyslipidemia and potentially mitigating CHD risk.
- Ongoing long-term studies aim to confirm additive clinical benefits.
Abstract:
Coronary heart disease (CHD) carries significant morbidity and mortality worldwide. Elevated LDL-cholesterol and reduced HDL-cholesterol levels are well-recognized CHD risk factors. Despite guideline recommendations for intensive therapy among patients at high risk for CHD to lower LDL-cholesterol, such lowering has failed to prevent approximately two-thirds of cardiovascular events. As a result of new data, guidelines have begun to focus on non-HDL-cholesterol, HDL-cholesterol and triglycerides as treatment targets, with the end result being a recommendation for combination therapy, such as niacin plus statin for the treatment of dyslipidemia. Compared with statin monotherapy, a combination of niacin and statin therapy provides beneficial effects on a broad range of lipid particles and some evidence suggests a further reduction in CHD risk. Recent studies have shown that the combination of a fixed dose of extended-release niacin plus simvastatin reduces non-HDL-cholesterol, LDL-cholesterol, triglycerides and total cholesterol:HDL-cholesterol ratio by approximately 50% while increasing HDL-cholesterol by 25%. The safety of this combination is consistent with the safety profiles of each individual component and is well tolerated. A long-term study is currently being conducted to evaluate whether this combination therapy confers an additive impact on clinical end points.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
07:07Controlled-release of Chlorine Dioxide in a Perforated Packaging System to Extend the Storage Life and Improve the Safety of Grape Tomatoes
Published on: April 7, 2017
Related Concept Videos
Dose Size and Dosing Frequency: Determination Methods
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Intrinsically Disordered Proteins
Lipid Digestion
What are Lipids?
Structure of Lipids